ANI Pharmaceuticals ANIP Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's gross margin?
- ANI Pharmaceuticals (ANIP) reported gross margin of 60.8% in Q1 2026.
- How has ANI Pharmaceuticals's gross margin changed year-over-year?
- ANI Pharmaceuticals's gross margin increased by 2.5% year-over-year, from 59.3% to 60.8%.
- What is the long-term trend for ANI Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's gross margin has grown at a 1.1% compound annual growth rate (CAGR), from 58.2% to 61.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.